Prevalence of Tinnitus and Its Associated Factors in the PERSIAN Guilan Cohort Study

Document Type : Original


1 Otorhinolaryngology Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

2 Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

3 Department of Biostatistics, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.


Tinnitus can be associated with many auditory and non-auditory factors, and its prevalence varies widely in the literature. There is no large sample of published data on tinnitus prevalence and its associated factors in Iran. Here, we analyzed the PERSIAN Guilan Cohort Study (PGCS) data and reported the prevalence of tinnitus and some of the risk factors related to tinnitus in the Iranian population.
Materials and Methods:
This cross-sectional study was conducted on 10520 men and women between 35 and 70 years old. The prevalence of tinnitus and associations between tinnitus and age, sex, habitat, marital status, employment status, socioeconomic status, educational level, lifestyle habits, and comorbid diseases were examined using simple and multiple logistic regression analyses.
The prevalence of tinnitus was 6.4% in this study. Based on the adjusted analysis, only older age (odds ratio: 2.60, 95% confidence interval: 1.88 – 3.60), residency in a rural area (odds ratio: 1.22, 95% confidence interval: 1.03 – 1.44), cigarette smoking (odds ratio:1.33, 95% confidence interval: 1.04 – 1.72), and having other comorbidities (odds ratio: 2.75, 95% confidence interval: 2.19 – 3.44) were related to tinnitus. In addition, the results of subgroup analyses by sex were mostly consistent with the overall analysis.
Our results revealed that the prevalence of tinnitus in the north of Iran is comparable with other communities. Age and other comorbidities were among the most related factors to tinnitus.


  1. Saberi A, Nemati S, Lili EK, Esmaeilpour H, Panahi R. Investigating the efficacy of fluoxetine vs. fluoxetine plus alprazolam (single therapy vs. combination therapy) in treatment of chronic tinnitus: A placebo-controlled study. Am J Otolaryngol. 2021;42(3):102898.
  2. Jalessi M, Farhadi M, Asghari A, Kamrava SK, Amintehran E, Ghalehbaghi S, et al. Tinnitus: an epidemiologic study in Iranian population. Acta Med Iran. 2013:886-91.
  3. Rhee J, Lee D, Suh MW, Lee JH, Hong Y-C, Oh SH, et al. Prevalence, associated factors, and comorbidities of tinnitus in adolescents. PloS one. 2020; 15(7):e0236723.
  4. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am. 2003; 36(2): 239-48.
  5. Xiong B, Liu Z, Liu Q, Peng Y, Wu H, Lin Y, et al. Missed hearing loss in tinnitus patients with normal audiograms. Hear res. 2019;384:107826.
  6. Scheffer AR, Mondelli MFCG. Tinnitus and hearing survey: cultural adaptation to Brazilian Portuguese.Braz J Otorhinolaryngol. 2021;87:28-34.
  7. Tan CM, Lecluyse W, McFerran D, Meddis R. Tinnitus and patterns of hearing loss. J Assoc Res Otolaryngol. 2013;14(2):275-82.
  8. Chung DY, Gannon RP, Mason K. factors affecting the prevalence of tinnitus. Audiology. 1984; 23(5):441-52.
  9. Michikawa T, Nishiwaki Y, Kikuchi Y, Saito H, Mizutari K, Okamoto M, et al. Prevalence and factors associated with tinnitus: a community-based study of Japanese elders. J Epidemiol. 2010: 1005180164-.
  10. Park KH, Lee SH, Koo J-W, Park HY, Lee KY, Choi YS, et al. Prevalence and associated factors of tinnitus: data from the Korean National Health and Nutrition Examination Survey 2009–2011. J Epidemiol. 2014:JE20140024.
  11. Mansour-Ghanaei F, Joukar F, Naghipour MR, Sepanlou SG, Poustchi H, Mojtahedi K, et al. The PERSIAN Guilan cohort study (PGCS). Arch Iran Med. 2019;22(1):39-45.
  12. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Eepidemiol. 2018;187(4):647-55.
  13. Kazemi Karyani A, Karmi Matin B, Soltani S, Rezaei S, Soofi M, Salimi Y, et al. Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study. BMC public health. 2019; 19(1):1-11.
  14. Quaranta A, Assennato G, Sallustio V. Epidemiology of hearing problems among adults in Italy. Scand Audiol Suppl. 1996;42:9-13.
  15. Dawes P, Fortnum H, Moore DR, Emsley R, Norman P, Cruickshanks K, et al. Hearing in middle age: a population snapshot of 40–69 year olds in the UK. Ear Hear. 2014;35(3):e44.
  16. Gibrin PCD, Melo JJ, Marchiori LdM, editors. Prevalence of tinnitus complaints and probable association with hearing loss, diabetes mellitus and hypertension in elderly. CoDAS; 2013.
  17. Hoffman HJ. Epidemiology of tinnitus. Tinnitus theory and management. 2004:16-41.
  18. Khedr EM, Ahmed MA, Shawky OA, Mohamed ES, El Attar GS, Mohammad KA. Epidemiological study of chronic tinnitus in Assiut, Egypt. Neuroepidemiology. 2010;35(1):45-52.
  19. Hasson D, Theorell T, Wallén MB, Leineweber C, Canlon B. Stress and prevalence of hearing problems in the Swedish working population. BMC public health. 2011;11(1):1-12.
  20. Bhatt IS. Prevalence of and risk factors for tinnitus and tinnitus-related handicap in a college-aged population. Ear hear. 2018;39(3):517-26.
  21. Nondahl DM, Cruickshanks KJ, Wiley TL, Klein R, Klein BE, Tweed TS. Prevalence and 5-year incidence of tinnitus among older adults: the epidemiology of hearing loss study. J Am Acad Audiol. 2002;13(6):323-31.
  22. Brown SC. Older Americans and tinnitus: a demographic study and chartbook. Center for Assessment and Demographic Studies, Gallaudet Research Institute; 1990.
  23. Martinez C, Wallenhorst C, McFerran D, Hall DA. Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England. Ear Hear. 2015;36(3):e69.
  24. Martines F, Sireci F, Cannizzaro E, Costanzo R, Martines E, Mucia M, et al. Clinical observations and risk factors for tinnitus in a Sicilian cohort. Eur Arch Otorhinolaryngol. 2015;272(10):2719-29.
  25. Xu X, Bu X, Zhou L, Xing G, Liu C, Wang D. An epidemiologic study of tinnitus in a population in Jiangsu Province, China. J Am Acad Audiol. 2011; 22(09):578-85.


  1. Mahboubi H, Oliaei S, Kiumehr S, Dwabe S, Djalilian HR. The prevalence and characteristics of tinnitus in the youth population of the United States. Laryngoscope. 2013;123(8):2001-8.
  2. Paschoal CP, Azevedo MFd. Cigarette smoking as a risk factor for auditory problems. Braz J Otorhinolaryngol. 2009;75:893-902.
  3. Nagaraj V. Effect of smoking on transient evoked otoacoustic emissions and contralateral suppression. Auris Nasus Larynx. 2010.
  4. Kim H-J, Lee H-J, An S-Y, Sim S, Park B, Kim SW, et al. Analysis of the prevalence and associated risk factors of tinnitus in adults. PloS one. 2015;10(5):e0127578.
  5. Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among US adults. Ame J Med. 2010;123(8):711-8.
  6. Nondahl DM, Cruickshanks KJ, Huang G-H, Klein BE, Klein R, Javier Nieto F, et al. Tinnitus and its risk factors in the Beaver Dam offspring study. Int J Audiol. 2011;50(5):313-20.
  7. Levi E, Bekhit EK, Berkowitz RG. Magnetic resonance imaging findings in children with tinnitus. Ann Otol Rhinol Laryngol. 2015;124(2):126-31.
  8. Huang Y-S, Koo M, Chen J-C, Hwang J-H. The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: A secondary case-control analysis of a nationwide, population-based health claims database. PloS one. 2017;12(11):e0187474.
  9. Basso L, Boecking B, Brueggemann P, Pedersen NL, Canlon B, Cederroth CR, et al. Gender-specific risk factors and comorbidities of bothersome tinnitus. Front Neurosci. 2020;14:706.
  10. Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021;268(9):3249-68.
  11. Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016; 34(23):2712.